Drug Type Chemical drugs |
Synonyms |
Target |
Mechanism BRIP1 modulators(BRCA1 interacting helicase 1 modulators), DHX9 inhibitors(DExH-box helicase 9 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Accent Therapeutics, Inc.Startup |
Active Organization Accent Therapeutics, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Colorectal Cancer | Preclinical | US | Accent Therapeutics, Inc.Startup | 07 Apr 2024 |